In humans, studies on patients with Laron syndrome (LS), whose IGF‐1 levels are extremely low, have reported a reduction in pro‐aging signaling, cancer, diabetes, and cognitive decline (Guevara‐Aguirre et al. 2011; Nashiro et al. 2017). This evidence concerns the gene IGF1 and Laron syndrome.